EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Establishment of a biosafe murine model of skeletal tuberculosis using Mycobacterium smegmatis

Yewei Jia iD, Yuhuai Guo, Yusheng Yang, Jie Zhang, Ziyang Zhang, Ying Qu, Jiulin Tan, Jie Shen, Nathachit Limjunyawong, Jianzhong Xu, Zehua Zhang, Fei Luo und 1 weitere

Animal Models and Experimental Medicine · 2026

DOI: 10.1002/ame2.70101 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Animal Models and Experimental Medicine, 2026. Verfasst von Yewei Jia und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China. Hauptthemen laut MEDLINE: Mycobacterium smegmatis, Disease Models, Animal, Tuberculosis, Osteoarticular, Mycobacterium Infections, Nontuberculous. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Southwest Hospital Boqing Innovation Fund, Fundings for Young Investigators of PLA, NSFC Key Projects of the Regional Innovation and Development Joint Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Skeletal tuberculosis (TB) remains a persistent clinical and research challenge due to its chronic course, osteolytic destruction, and the limitations of existing animal models, which often require high‐level biosafety containment or fail to replicate human skeletal pathology.

Methods

This study developed a biosafe, accessible, and versatile murine model of skeletal TB using Mycobacterium smegmatis , a fast‐growing, nonpathogenic mycobacterial species with high genomic homology to Mycobacterium tuberculosis. Three infection routes—subperiosteal calvarial injection, intratibial injection, and intracardiac inoculation—were systematically evaluated for their ability to induce localized versus disseminated bone infection under standard biosafety level (BSL)‐1 conditions.

Results

Subperiosteal calvarial and intratibial injection of M. smegmatis induced localized bone lesions characterized by osteolysis, sequestrum formation, granulomatous inflammation, and increased osteoclast activity. Intratibial infection additionally triggered compartment‐specific immune responses, including neutrophil and macrophage expansion, transient B‐cell depletion, and activation of interferon‐γ + (IFN‐γ + ) T cells, reflecting active immune remodeling at the infection site. Systemic dissemination via intracardiac injection reproducibly generated progressive vertebral and tibial bone destruction with organized granuloma formation and immune cell infiltration but without prominent sequestrum formation. Compared to intratibial infection, intracardiac delivery exhibited lower intragroup variability and more closely recapitulated the diffuse progression of extrapulmonary skeletal tuberculosis.

Conclusions

This M. smegmatis –based murine model provides a straightforward, reliable, and immunopathologically relevant platform for exploring host–pathogen dynamics, immune‐driven bone destruction, and early‐stage therapeutic testing in skeletal TB, all within standard BSL‐1 laboratories. This model fills a critical gap by enabling BSL‐1 research into skeletal TB mechanisms and drug development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium smegmatisDisease Models, AnimalTuberculosis, OsteoarticularMycobacterium Infections, NontuberculousAnimalsMiceFemaleMice, Inbred C57BLContainment of Biohazards

Stichwörter der Autor:innen

Mycobacterium smegmatisbone tuberculosismurine modeltuberculosis

Autor:innen und Institutionen

  • Department of Orthopaedics, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
  • Center of Research Excellence in Allergy & Immunology, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.

ORCID-Profile: Yewei Jia

Förderung

  • Southwest Hospital Boqing Innovation Fund
  • Fundings for Young Investigators of PLA
  • NSFC Key Projects of the Regional Innovation and Development Joint Fund
  • China Postdoctoral Science Foundation
  • National Natural Science Foundation of China
  • Southwest Hospital Postdoctoral Starting Fund
  • Southwest Hospital

Zitieren

APA

Jia, Y., Guo, Y., Yang, Y., Zhang, J., Zhang, Z., Qu, Y., Tan, J., Shen, J., Limjunyawong, N., Xu, J., Zhang, Z., Luo, F., & Dou, C. (2026). Establishment of a biosafe murine model of skeletal tuberculosis using Mycobacterium smegmatis. Animal Models and Experimental Medicine. https://doi.org/10.1002/ame2.70101

Vancouver

Jia Y, Guo Y, Yang Y, Zhang J, Zhang Z, Qu Y, et al. Establishment of a biosafe murine model of skeletal tuberculosis using Mycobacterium smegmatis. Animal Models and Experimental Medicine. 2026. doi:10.1002/ame2.70101

BibTeX
@article{Jia2026,
  author = {Jia, Yewei and Guo, Yuhuai and Yang, Yusheng and Zhang, Jie and Zhang, Ziyang and Qu, Ying and Tan, Jiulin and Shen, Jie and Limjunyawong, Nathachit and Xu, Jianzhong and Zhang, Zehua and Luo, Fei and Dou, Ce},
  title = {Establishment of a biosafe murine model of skeletal tuberculosis using Mycobacterium smegmatis},
  journal = {Animal Models and Experimental Medicine},
  year = {2026},
  doi = {10.1002/ame2.70101}
}
Kostenlos starten →